Related by context. All words. (Click for frequent words.) 66 Nimotuzumab 66 ophthalmic indications 65 autoimmune indications 64 volociximab 64 apaziquone 64 tamibarotene 64 Exelixis compounds 64 MEK inhibitors 64 Orphan Drug designation 63 Orphan Drug designations 63 SARMs 63 Allovectin 7 R 63 investigational therapies 63 hematological malignancies 63 TELINTRA 63 AQ4N 63 fipamezole 63 IMiDs 63 FOLOTYN ® 63 investigational compounds 63 subcutaneous formulation 62 immunological diseases 62 Zemiva TM 62 Panzem R NCD 62 angioedema indications 62 Neulasta ® 62 hypoxia activated prodrug 62 #D#C# 62 clofarabine 62 IAP inhibitors 62 DepoBupivacaine TM 62 JAK inhibitor 62 ularitide 62 Nexavar ® 62 Mepact 62 oncological indications 62 oral prodrug 62 ulimorelin 62 Perifosine 62 talactoferrin 62 Campath ® 62 Solazed TM 62 bendamustine HCl 62 Carfilzomib 62 hematological cancers 62 XL# XL# 62 proteasome inhibitor 61 Cellegesic 61 Insegia 61 Vicinium TM 61 HGS# 61 RNAi therapeutic targeting 61 Allovectin 7 ® 61 ophthalmic diseases 61 Soliris TM eculizumab 61 Shigamabs ® 61 Amrubicin 61 R sorafenib tablets 61 TRISENOX 61 MOZOBIL 61 intravenous formulations 61 drug ISA# 61 Cx# [002] 61 Factor VIIa 61 NovaBay Aganocide compounds 61 ALN PCS 61 sodium thiosulfate STS 61 Personalized Immunotherapy 61 AzaSite Plus 61 injectable formulation 61 hematologic malignancies 61 Panzem R 61 AEG# 61 IAP inhibitor 61 JAK1 61 Orphan Drug status 61 investigational humanized monoclonal antibody 61 hyperimmune products 61 DOS# 61 Orphan Drug 61 targeted radiotherapeutic 61 Azixa 61 Archexin 61 Onalta 61 RH1 61 Modrenal R 61 Belinostat 60 eniluracil 60 derivatives Radilex TM 60 Novantrone R 60 tezampanel 60 XL# anticancer compounds 60 BENLYSTA ® 60 PF # [001] 60 receptor tyrosine kinase inhibitor 60 PRT# 60 PDE4 inhibitor 60 Civacir 60 Viprovex R 60 topical NSAID 60 TREANDA 60 Entereg R 60 Dicer Substrate Technology 60 Tamibarotene 60 AzaSite Xtra 60 Allovectin 7 60 SERMs 60 antisense inhibitors 60 Vandetanib 60 anticancer compound 60 L BLP# 60 RELISTOR ® 60 sorafenib tablets 60 mitoxantrone concentrate 60 Aloxi R 60 Cetrorelix 60 myeloproliferative disorders 60 Clolar ® 60 Onalta TM 60 markets Gelclair R 60 GW# [003] 60 Dapagliflozin 60 TRISENOX R 60 Æterna Zentaris 60 topical anti infective 60 Rebif ® 60 vaccines oncolytic virus 60 CTLA4 Ig 60 ZADAXIN ® 60 RNAi therapeutic 60 POSIDUR 60 histone deacetylase HDAC inhibitor 60 Azedra 60 Genasense ® 60 orally administered inhibitor 60 selective immunoproteasome inhibitor 60 OPAXIO 60 PNP inhibitor 60 erlotinib Tarceva ® 60 alvimopan 60 ARIKACE ™ 60 GTC recombinant human 60 TAFA# 60 generation proteasome inhibitor 59 HuLuc# 59 SYCREST 59 anticancer therapies 59 Annamycin 59 anticancer agents 59 Nanobody ® 59 Dacogen injection 59 ANYARA 59 Thrombin topical Recombinant 59 gastrointestinal disorders ATI 59 Ceflatonin 59 Nanobody 59 mitogen activated ERK kinase 59 MOVIPREP R 59 Icatibant 59 HCV protease inhibitors 59 IgG1 monoclonal antibody 59 therapeutic antibody 59 Evoltra ® 59 novel antibody therapeutics 59 EOquin 59 Eligard R 59 otelixizumab 59 prokinetic agent 59 tivozanib 59 PXD# 59 ONSOLIS 59 lintuzumab SGN 59 Oracea ® 59 Orally administered 59 MyVax R 59 Solasia 59 PREOS R 59 multiple sclerosis rheumatoid arthritis 59 Loramyc 59 ADP receptor antagonist 59 PLK1 SNALP 59 XL# XL# XL# XL# 59 Augment TM 59 regadenoson 59 lung pancreatic 59 JAK inhibitors 59 p# inhibitor 59 TRAIL receptor antibodies 59 ALN TTR 59 Adenuric R 59 XIAFLEX ® 59 ASONEP 59 Fibrillex TM 59 Genasense evaluating 59 Iluvien ® 59 elinogrel 59 bevacizumab Avastin ® 59 biologic therapies 59 ocular formulation 59 Loramyc R 59 YONDELIS 59 Proxinium TM 59 ecallantide 59 ThermoDox R 59 Friedreich Ataxia FRDA 59 cancer immunotherapies 59 sarcoma melanoma 59 HuMax CD4 59 Darinaparsin 59 Exherin 59 QUADRAMET R 59 CEQ# 59 humanized monoclonal antibody 59 LHRH antagonists 59 mocetinostat MGCD# 59 Phase #b/#a clinical 59 generation purine nucleoside 59 diagnostic molecular imaging 59 methylnaltrexone 59 chemotherapy induced neutropenia 59 ruxolitinib 59 docetaxel Taxotere R 59 RhuDex ® 59 HSP# inhibitor 59 registrational studies 59 RNA antagonist 59 calcineurin inhibitors 59 pan HDAC inhibitor 59 dermatology therapies 59 Flutiform TM 59 leading oral taxane 59 including eniluracil ADH 59 refractory Hodgkin lymphoma 59 CINTREDEKIN BESUDOTOX 59 CoTherix 59 Onco TCS 59 luliconazole 59 amrubicin 58 LEP ETU 58 dasatinib Sprycel ® 58 faropenem 58 oropharyngeal candidiasis 58 bafetinib 58 novel VDA molecule 58 liposomal formulation 58 anticancer therapy 58 Clevudine 58 Tavocept 58 ZEFTERA TM Zevtera TM 58 FOLOTYN 58 oral ridaforolimus 58 therapeutics 58 Neuradiab 58 Behcet uveitis 58 TheraCIM 58 Virulizin ® 58 systemic immunosuppressive drugs 58 Aurexis 58 metaglidasen 58 multi kinase inhibitor 58 CYT# potent vascular disrupting 58 Orphan Drug Status 58 Bezielle 58 kinase inhibitor 58 Orphan Medicinal Product 58 TYZEKA 58 skeletal metastases 58 Azedra TM Onalta TM 58 Raptiva ® 58 albinterferon alfa 2b 58 deforolimus 58 Amigal 58 GED aPC 58 atacicept 58 ThermoDox ® 58 forodesine HCl 58 class mGluR5 inhibitor 58 vascular disrupting agent 58 SEBIVO 58 Zavesca r 58 Intravenous Human 58 Bicifadine 58 Mimpara 58 Cloretazine ® 58 histone deacetylase inhibitor 58 daclizumab 58 GlycoPEG GCSF 58 Fludara ® 58 BEMA Buprenorphine 58 cyclophilin inhibitor 58 colon lung 58 Exherin TM 58 vidofludimus 58 candidate AQ4N 58 CCR9 antagonist 58 sumatriptan DosePro 58 refractory APL 58 acyclovir Lauriad R 58 ALD# 58 Cintredekin Besudotox 58 inflammatory diseases 58 MEK inhibitor 58 anticancer agent 58 antiangiogenesis therapies 58 selective kinase inhibitor 58 personalized immunotherapy 58 cutaneous T cell 58 lexidronam injection 58 mertansine 58 ZEVALIN ® 58 Shigamabs R 58 JAK2 inhibitor 58 depsipeptide 58 Vasovist 58 Combidex 58 Pirfenidone 58 radiotherapeutic 58 Traficet EN 58 docetaxel Taxotere ® 58 CORLUX CORT # 58 REOLYSIN ® 58 LEUKINE 58 equine osteoarthritis 58 gastro intestinal inflammation 58 INCB# [002] 58 Surfaxin LS 58 Loramyc ® 58 solid tumors 58 Sebivo 58 cognitive impairment associated 58 COLAZAL R 58 antisense drugs 58 humanized anti 58 siRNA therapeutics 58 Ganite R 58 Orphan Drug Designation 58 investigational monoclonal antibody 58 acute HAE attacks 58 oral proteasome inhibitor 58 valtorcitabine 58 Visudyne R 58 methylnaltrexone bromide 58 radionuclide therapy 58 ATryn ® 58 YONDELIS R 58 Plenaxis R 58 rheumatoid arthritis psoriatic arthritis 58 registrational 58 anticancer compounds 58 vitreoretinal disorders 58 NTDDS 58 radiation sensitizer 58 ADVEXIN 58 Preclinical studies suggest 58 ONX 58 CB2 selective receptor agonist 58 Hsp# inhibition 58 NEBIDO R 58 Apokyn R 58 sodium glucose cotransporter 57 HZT 57 NXL# 57 herpetic keratitis 57 ONCONASE 57 Homspera TM 57 TRANSDUR Sufentanil 57 immunotherapeutic 57 angiogenesis inhibitor 57 Firazyr ® 57 Myocet 57 Lupuzor 57 antisense drug 57 Prestara 57 FUSILEV ® 57 tafluprost 57 diabetic neuropathic pain 57 pralatrexate 57 topical ophthalmic 57 severe gastroparesis 57 Aerosurf 57 NNR Therapeutics 57 Virulizin R 57 hormone gastrin 57 Aviptadil 57 MNTX 57 Daclizumab 57 Cladribine Tablets 57 prostone 57 Cinryze ™ 57 MTP inhibitor 57 diarrhea predominant irritable 57 small molecule thrombopoietin 57 Fast Track designation 57 M2 subunit 57 Zelrix 57 BAY #-# 57 Vascular Wrap TM 57 peripherally acting 57 IV Busulfex 57 Benlysta belimumab 57 Cethrin R 57 TORISEL 57 IL# PE#QQR 57 thrombolytic agent 57 ZADAXIN 57 advanced metastatic renal 57 AAG geldanamycin analog 57 ENMD # 57 Troxatyl 57 Marqibo TM 57 diabetic nephropathy 57 LHRH antagonist 57 psoriasis rheumatoid arthritis 57 Octreolin 57 Junovan TM 57 Nexavar sorafenib 57 tiapamil 57 subsidiaries visit http:/www.apricusbio.com 57 RECOTHROM R 57 TEMODAL 57 ixabepilone 57 Ceflatonin R 57 XL# XL# XL# 57 P#X# antagonist 57 HepaSphere 57 recombinant biopharmaceutical 57 refractory PTCL 57 Apaziquone 57 CDP# 57 Serdaxin 57 Zerenex 57 phase IIb clinical 57 Zenvia ™ 57 torezolid phosphate 57 samarium Sm 57 incyclinide 57 therapeutic peptide 57 tyrosine kinase inhibitor 57 VEGF inhibitors 57 R bendamustine hydrochloride 57 Intravenous CP 57 sunitinib malate 57 2 inhibitor CYT# 57 Squalamine 57 inhaled formulation 57 Nippon Kayaku 57 novel anticancer 57 forodesine 57 polyneuropathy HIV DSP 57 gastrointestinal disorders characterized 57 therapeutic monoclonal antibodies 57 GEM OS2 57 orphan medicinal product 57 TRISENOX ® 57 Junovan 57 Xanafide 57 Vidaza R 57 ARRY # 57 tezampanel NGX# 57 IMGN# 57 belinostat 57 dihydrochloride Tablets 57 AnGes 57 huC# DM4 57 Clavis Pharma 57 Preotact 57 anti infective treatments 57 SonoLysis 57 Neulasta R 57 rxRNA 57 bardoxolone 57 Multiferon R 57 colorectal lung 57 ALN VSP 57 Targretin 57 CR# vcMMAE 57 DU #b 57 TNF Tumor Necrosis Factor 57 XL# [003] 57 Irinotecan 57 ORTHOVISC mini 57 Hsp# inhibitors 57 orally bioavailable 57 intravenous formulation 57 BEMA Fentanyl 57 LEVADEX TM 57 ozarelix 57 ATL# [002] 57 rNAPc2 57 Alpharadin 57 entinostat 57 Azedra TM 57 Oracea TM 57 Ecallantide 57 OXi# 57 Lubiprostone 57 post herpetic neuralgia PHN 57 ospemifene 57 topical formulations 57 Clofarabine 57 Octreotide 57 VALSTAR TM 57 Tarceva TM 57 haematological malignancies 57 ONCASPAR 57 ganetespib 57 oncology therapeutics 57 preclinical 57 Lovaza TM 57 Lenalidomide 57 commercialize telaprevir 57 vinca alkaloids 57 Navelbine ® 57 veltuzumab 57 candidates Azedra TM 57 romidepsin 57 FGFR 57 5 HT3 antagonist 57 orphan drug 57 HCV polymerase inhibitors 57 investigational compound 57 CCX# 57 Tofacitinib 57 Pixantrone 57 reslizumab 57 nucleoside analog 57 Amplimexon 57 BiTE antibody 57 Interferon alpha 57 Taiho Pharmaceutical 57 Chrysalin 57 CD# monoclonal antibody 57 dirucotide MBP# 57 anti angiogenic agents 57 nitric oxide donating 57 Cinryze TM 57 PEGylation technology 57 HGS ETR1 57 trastuzumab Herceptin R 57 bexarotene 57 dirucotide 57 PREOS 57 SECTA therapy 57 Dalbavancin 56 Fast Track Designation 56 ocular diseases 56 voclosporin 56 cintredekin besudotox 56 alpha interferons 56 maribavir 56 opioid induced constipation OIC 56 Bendavia 56 AZX# 56 VEGF Trap 56 Firazyr 56 ZFP Therapeutics 56 Urocidin 56 Alnylam RNAi 56 clinically validated targets 56 Viprovex TM 56 relapsed leukemia 56 Abiraterone acetate 56 relapsed refractory multiple myeloma 56 R roscovitine 56 dasatinib Sprycel 56 CD# CEA 56 immuno inflammatory diseases 56 VEGF receptors 56 PDX pralatrexate 56 immune modulators 56 Pimavanserin 56 pancreatic enzyme replacement 56 isoform selective 56 tesetaxel 56 DPX Survivac 56 ATryn R 56 preclinical models 56 alvespimycin 56 TLR8 agonist 56 CTAP# Capsules 56 Genasense R 56 prophylactic vaccines 56 Palifosfamide 56 Serostim ® 56 TOCOSOL Paclitaxel 56 Ciclesonide 56 AP# [003] 56 PI3K inhibitors 56 FDA Orphan Drug 56 Ethyol 56 RGB # 56 ALN TTR# 56 RECOTHROM ® 56 Onconase 56 Velcade bortezomib 56 gastrointestinal stromal tumors 56 Sudhir Agrawal D.Phil 56 Marketing Authorisation Application 56 Relivar 56 KL4 surfactant 56 Somatuline R Autogel R 56 NGX# 56 OMAPRO 56 ProLindac 56 satraplatin 56 refractory multiple myeloma 56 ovarian lung 56 lucinactant 56 GVAX cancer 56 kinase inhibitors 56 oral nucleoside analogue 56 LymphoStat B TM 56 LBH# 56 immunomodulatory therapy 56 ® bortezomib 56 relapsed ovarian cancer 56 CytoSorb TM 56 immunotherapeutics 56 SNT MC# 56 mGluR5 negative 56 pertuzumab 56 biosurgical 56 chemotherapeutic agents 56 TLR9 agonists 56 skeletal muscle contractility 56 2 methoxyestradiol 56 cinacalcet HCl 56 MT# MEDI 56 lapatinib Tykerb 56 allosteric modulator NAM 56 Gelclair R 56 zanolimumab 56 OncoVEX GM CSF 56 non alcoholic steatohepatitis 56 vascular disrupting agents 56 polymerase inhibitors 56 XmAb# 56 EGFR HER2 56 paclitaxel Taxol 56 OZURDEX ® 56 LNP formulations 56 catheter occlusion 56 refractory chronic lymphocytic 56 acne impetigo 56 neuropathic pain 56 ridaforolimus 56 monoclonal antibody conjugated 56 fibrotic diseases 56 XIFAXAN R 56 OvaRex R 56 adecatumumab 56 Kuvan R 56 proteasome inhibitors 56 paclitaxel Taxol ® 56 TKM ApoB 56 Anidulafungin 56 elotuzumab 56 Liprotamase 56 Microplasmin 56 Nanobodies 56 Rectogesic 56 multiple myeloma MM 56 gastrointestinal mucositis 56 ATL# [001] 56 intravesical instillation 56 SinuNase TM 56 inflammatory disorders 56 OHR/AVR# 56 histone deacetylase HDAC inhibitors 56 Syncria 56 Leukine 56 interferon gamma 1b 56 BENLYSTA 56 neuroendocrine cancers 56 MAXY alpha 56 axitinib 56 obatoclax 56 TKB# 56 pegylated interferons 56 PEG SN# 56 carfilzomib 56 Advagraf 56 REMOXY ® 56 HCD# [002] 56 cutaneous T 56 OMNARIS HFA 56 MCSP respectively 56 Cethrin 56 Herceptin trastuzumab 56 Vertex retains 56 HDAC inhibitor 56 Allovectin 7 r 56 tanespimycin 56 Anticalin R 56 Argatroban 56 Alzhemed TM 56 Cancidas 56 rheumatoid arthritis thrombocytopenia 56 visilizumab 56 Fortigel 56 Folotyn 56 familial amyloidotic polyneuropathy FAP 56 hematological indications 56 opioid induced constipation 56 therapeutic modalities 56 alpha folate receptor 56 Panzem 56 HIV integrase inhibitor 56 MAXY G# 56 PGL# 56 TroVax ® 56 Evoltra TM 56 epigenetic therapies 56 rheumatoid arthritis psoriasis 56 XP# XP# 56 CINOD 56 Homspera 56 RITUXAN 56 LUCASSIN 56 Rapinyl 56 Zingo TM 56 teduglutide 56 tranilast 56 Tarceva erlotinib 56 Kyowa Hakko Kirin 56 EGFR inhibitors 56 commercialize dutogliptin 56 EOquin TM 56 Cleviprex TM clevidipine 56 delta isoform 56 Erbitux cetuximab 56 HGS ETR1 mapatumumab 56 Teysuno 56 trabectedin 56 Oxaliplatin 56 mu opioid receptor antagonist 56 IMiD 56 mifamurtide 56 Taxotere docetaxel 56 motexafin gadolinium Injection 56 peptide conjugated 56 Symadex 56 Trizytek 56 GAP #B# 56 synthetic retinoid 56 BRAF inhibitor 56 Ostarine ™ 56 MAP# 56 prodrugs 56 IMC #F# 56 Rescula 56 dextromethorphan quinidine 56 EndoTAG 56 Dacetuzumab 56 Debio 56 kidney urologic 56 ONSOLIS TM 56 humanized antibodies 56 Vorinostat 56 vaccine GRNVAC1 56 novel oral anticoagulant 56 Eraxis 56 Orapred ODT 56 Phenoptin 56 Ambrisentan 56 Telavancin 56 docetaxel Taxotere 56 PrevOnco ™ 56 Vidaza azacitidine 56 PEG Interferon lambda 56 Orencia abatacept 56 mitiglinide 56 thymalfasin 56 molecular imaging radiopharmaceutical 56 ddRNAi 55 VDAs 55 Application MAA 55 IMA# 55 LentiVector technology 55 Invicorp R 55 Zybrestat 55 MAGE A3 ASCI 55 Delta opioid receptor 55 EP #R 55 Panzem NCD 55 HspE7 55 Albugon 55 AMPK activators 55 novel histone deacetylase 55 Handok 55 Aflibercept 55 Zenyaku Kogyo 55 GABITRIL 55 Selective Electrochemical Tumor Ablation 55 Evoltra 55 targeted kinase inhibitor 55 candidates bavituximab 55 BiovaxID TM 55 preclinical studies 55 Phase Ib clinical trials 55 Pharmos proprietary 55 BEMA TM Fentanyl 55 photodisinfection 55 thetreatment 55 antitumor activity 55 post menopausal osteoporosis 55 systemic fungal infections 55 SCH # 55 solid organ transplantation 55 orphan designation 55 AGGRASTAT ® 55 R bortezomib 55 ADVEXIN p# therapy 55 PEGylated Fab fragment 55 Ridaforolimus 55 outlicensing 55 Combo Stent 55 POSIDUR TM ELADUR TM 55 Urocidin TM 55 biologic therapy 55 Voreloxin 55 evaluating pirfenidone 55 terlipressin 55 VISICOL R 55 hepatitis C HCV 55 ESBA# 55 oncolytic virus therapies 55 NeoVisc ® 55 Actemra tocilizumab 55 Trofex TM 55 REBETOL combination therapy 55 nucleoside analogs 55 novel immunomodulatory 55 refractory metastatic colorectal cancer 55 vinorelbine emulsion 55 dihydrochloride 55 LymphoStat B belimumab 55 Everolimus 55 Revimmune 55 CD# antibody [001] 55 linaclotide 55 Tezampanel 55 Poly ICR 55 anti EGFR antibody 55 MGCD# [001] 55 Aplidin 55 Indaflex TM 55 danoprevir 55 Poly ICLC 55 Epothilones 55 Multiferon ® 55 Linjeta TM 55 DDP# 55 Onalta ™ 55 THALOMID 55 PHX# 55 Unit Dose Budesonide 55 confirmatory Phase III 55 imatinib Gleevec ® 55 ITAX 55 darinaparsin ZIO 55 XIAPEX ® 55 Synavive 55 TLR antagonists 55 multitargeted 55 selective modulator 55 Methylnaltrexone 55 Emezine 55 relapsing forms 55 HQK 55 hepatitis B HBV 55 recurrent NSCLC 55 vosaroxin 55 Provectus Pharmaceuticals specializes 55 tumor xenograft models 55 selective androgen receptor modulators 55 Exelixis XL# 55 CA4P 55 DPP4 inhibitor 55 Kuvan TM sapropterin 55 SomatoKine 55 Vivecon 55 microtubule inhibitor 55 OvaRex ® MAb 55 immunomodulators 55 Sanvar R 55 luteinizing hormone releasing 55 BioSTAR R 55 nimotuzumab 55 Tracleer r 55 Actimmune ® 55 modified glutathione analog 55 FACTIVE R gemifloxacin 55 Peginterferon alfa 2b 55 CD3 monoclonal antibody 55 targeting CD# 55 advanced hepatocellular carcinoma 55 Gleevec Glivec 55 ATG Fresenius S 55 Ganciclovir 55 acting muscarinic antagonist 55 anti inflammatory NSAID 55 oral deforolimus 55 OMP #M# 55 mixed dyslipidemia 55 oncolytic 55 S1P antibody 55 Tyrima 55 KIACTA ™ 55 pain palliation 55 Trovax 55 fluoropyrimidine 55 Solazed ™ 55 Pazopanib 55 siRNA therapeutic 55 beta interferons 55 silodosin 55 L MTP PE 55 Solazed 55 Azilect ® 55 Pafuramidine 55 JOULFERON 55 IL# PE 55 Revlimid lenalidomide 55 combinability 55 IMiDs ® compound 55 LibiGel ® 55 Hsp# inhibitor 55 anti thrombotic 55 DELATESTRYL R 55 zileuton 55 CORT # 55 castrate resistant prostate cancer 55 small molecule tyrosine 55 ISIS # 55 5 HT6 55 KNS # 55 topically applied SEPA 55 enzastaurin 55 painful diabetic neuropathy 55 inflammatory autoimmune 55 postoperative ileus POI 55 oral RSD# 55 TG# [003] 55 PEG INTRON 55 Veronate 55 signal transduction inhibitors 55 HepeX B TM 55 NB S# 55 PrevOnco 55 NEUMUNE 55 immunotherapies 55 thalidomide Thalomid 55 HepeX B 55 sublingual tablets 55 Alemtuzumab 55 Avastin bevacizumab 55 Soliris eculizumab 55 Bortezomib 55 systemic lupus erythematosus lupus 55 HepaGam B R 55 acetonide FA 55 diagnostic biomarkers 55 valopicitabine 55 Zorbtive TM 55 Leukine ® 55 myelofibrosis polycythemia vera 55 MEK Inhibitor 55 DepoDur 55 Vaprisol 55 neuropathic pain metabolic diseases 55 Topical Interferon Alpha 2b 55 Cobalamin 55 lomitapide 55 bazedoxifene 55 Vidofludimus 55 cetuximab Erbitux R 55 nitric oxide donating prostaglandin 55 inflammatory autoimmune diseases 55 myeloproliferative diseases 55 SNALP technology 55 Endotis 55 Increlex TM 55 induced macular edema 55 Inhalation Solution 55 Glassia 55 metastatic colorectal 55 Apricus Bio 55 PS# [001] 55 Litx 55 Bafetinib 55 MGCD# [002] 55 cMET 55 ocular hypertension 55 metastatic neuroendocrine tumors 55 platforms GVAX 55 neovascular age 55 CYT# novel 55 commercialize AzaSite